Purchase date was "Sniper" state instruments were sued infringement

Today, for the Ribon instrument (300206,SZ) is an extremely special and important day, after a long wait, the company will accept the vast number of investors real gold and silver review-online purchase.　　But today, the state instruments have to face the rival Shenzhen, the Biological Medical Electronics Co.　　Some products are sued tort should be static for investors to apply for the state instruments, but today suddenly released a enough to make everyone feel shocked announcement. Ribon instrument in the announcement, Shenzhen, a biological Medical Electronics Co., Ltd. (hereinafter referred to as Mai Rui Company) on April 8 to the Shenzhen Intermediate People's Court (hereinafter referred to as Shenzhen) filed a lawsuit, said the company's multi-parameter monitoring products violate the company's intellectual property.　　Shenzhen Chinese court has confirmed that Mai Rui company sued the company intellectual property infringement cases are true. The announcement showed that the company "immediately stop the infringement, immediately stop the manufacture, promise to sell and sell infringing products, destroy the infringing products and semi-finished goods in stock, destroy the advertising and promotional materials related to infringing products, and delete the advertisements and advertisements on the products on the Internet."　　Require the company to compensate for the infringement of the patent rights of 20 million yuan, and the infringement of trade secrets of the Act of compensation for 5 million yuan.　　According to the information previously reported in the media, Mai Rui said Ribon instrument of the Multi-parameter Monitoring series of products "M8 patient Monitor", "M9 Patient Monitor", "M80 Patient Monitor" and "M50 patient monitor", suspected infringement of Mai Rui Company invention Patent, utility model patent three and trade secrets. So why is the company holy? Why did the state instrument suddenly appeal when it was about to purchase? This was described in the prospectus published by the Ribon instrument, as one of the main medical electronic equipment suppliers, Mai Rui Company is the main domestic competitors, products involved in guardianship, clinical testing, digital ultrasound, radiological imaging, veterinary equipment and other fields, in the field of monitoring and digital ultrasound to form a competitive relationship with the company. September 2006, the company listed on the NYSE.　　From gross profit margin, the state instruments up to 59.12%, but also slightly higher than the company's 57.43%. Today's purchase or affected for the company's accusations, the state instrument in the announcement also gave a clear response, said the company's related monitoring products are independent research and development, did not violate the company's patent. Nearly three years, the company continued to maintain accounting for more than 10% of business income research and development investment, in the field of guardianship products through continuous independent research and development has been covered by the main control platform, detection module, integration and other key areas of 12 proprietary core technology, up to now 3 invention patents, 7 utility model patents,　　7 Designs patents and 21 software copyrights. At the same time, the state instrument also in the announcement on the impact of the lawsuit, said that even if the company involved in the infringement case, the company involved in the case of infringement of the product sales of nearly 3 years, respectively, 11.4463 million yuan,12.5895 million yuan, 39.1652 million yuan, respectively, accounting for the current income ratio of 6.51%, 5.5%, 12.22%, the gross margin of 5.3551 million yuan, 6.6335 million yuan, 20.964 million yuan, respectively, in the current period of gross margin of 5.55%, 5.03%,　　11.02%, the ratio is small, does not affect the company's continued ability to operate. A person in the industry said that although the Ribon instrument denied infringement, and said that even if the impact of the lawsuit is not small, but this incident is likely to have a significant impact on the purchase today. Responsible Editor: NF045